Emergent Biosolutions Inc (EBS) — Financial Flexibility Index
Emergent Biosolutions Inc (EBS) has a Financial Flexibility Index of -0.04x as of March 2026. Free cash flow of $-31.40 Million (operating CF $-33.80 Million minus capex $2.40 Million) represents 0% of total liabilities ($797.30 Million). Check Emergent Biosolutions Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Emergent Biosolutions Inc Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Emergent Biosolutions Inc across 22 annual periods. See Emergent Biosolutions Inc (EBS) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Emergent Biosolutions Inc (2004–2025)
Year-by-year free cash flow to debt coverage for Emergent Biosolutions Inc. For the full company profile including market capitalisation, see EBS company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | $184.40 Million | $170.60 Million | $796.00 Million | ▲ +157.5% |
| 2024 | 0.09x | $81.60 Million | $58.70 Million | $906.90 Million | ▲ +168.3% |
| 2023 | -0.13x | $-154.70 Million | $-206.30 Million | $1.17 Billion | ▼ -386.9% |
| 2022 | 0.05x | $81.70 Million | $-34.10 Million | $1.78 Billion | ▼ -88.7% |
| 2021 | 0.41x | $546.10 Million | $321.10 Million | $1.35 Billion | ▼ -14.2% |
| 2020 | 0.47x | $678.80 Million | $536.90 Million | $1.44 Billion | ▲ +113.0% |
| 2019 | 0.22x | $274.90 Million | $188.00 Million | $1.24 Billion | ▲ +137.4% |
| 2018 | 0.09x | $113.90 Million | $41.80 Million | $1.22 Billion | ▼ -94.4% |
| 2017 | 1.67x | $262.97 Million | $208.14 Million | $157.86 Million | ▲ +380.1% |
| 2016 | 0.35x | $129.74 Million | $53.49 Million | $373.91 Million | ▲ +49.1% |
| 2015 | 0.23x | $89.27 Million | $44.46 Million | $383.57 Million | ▼ -36.2% |
| 2014 | 0.36x | $142.99 Million | $112.32 Million | $392.06 Million | ▼ -63.9% |
| 2013 | 1.01x | $138.99 Million | $96.97 Million | $137.47 Million | ▲ +32.1% |
| 2012 | 0.77x | $93.49 Million | $39.64 Million | $122.10 Million | ▲ +45.2% |
| 2011 | 0.53x | $68.62 Million | $14.59 Million | $130.14 Million | ▼ -45.1% |
| 2010 | 0.96x | $121.64 Million | $99.54 Million | $126.76 Million | ▲ +51.7% |
| 2009 | 0.63x | $63.80 Million | $30.51 Million | $100.87 Million | ▲ +105.6% |
| 2008 | 0.31x | $28.13 Million | $7.32 Million | $91.44 Million | ▼ -68.3% |
| 2007 | 0.97x | $99.42 Million | $55.45 Million | $102.35 Million | ▲ +160.8% |
| 2006 | 0.37x | $37.17 Million | $-4.06 Million | $99.78 Million | ▼ -69.0% |
| 2005 | 1.20x | $48.78 Million | $42.25 Million | $40.59 Million | ▲ +110.9% |
| 2004 | 0.57x | $26.27 Million | $9.20 Million | $46.11 Million | — |